Keytruda
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Keytruda in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Keytruda.
1
Global Revenue Ranking
5
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Keytruda
Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer
DeSimone was formerly President of US Oncology at Merck
The combination treatment showed a 35% reduction in the risk of disease progression
Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths
Bladder cancer affects more than 614,000 people globally each year
More than 9,700 new cases of endometrial cancer are diagnosed every year in the UK
A new restructuring programme has been approved to support the initiative
‘Hot’ tumours, breast cancer breakthroughs and holistic treatment were the standouts at this year’s event
More than 72,680 new cases of the disease are expected to be diagnosed in the US this year
Approximately 20,890 cases of the disease are expected to be diagnosed in the US this year
Triple-negative breast cancer accounts for approximately 15% of all cases of the disease
Approximately 614,000 people are diagnosed with bladder cancer globally every year
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology